Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ataluren

EU orphan designation number: EU/3/12/1010   
Active ingredient: Ataluren
Indication: Treatment of Becker muscular dystrophy
Sponsor: PTC Therapeutics, Limited
Lakeside House, Office G33a, 1 Furzeground Way, Stockley Park E. Uxbridge, UB11 1BD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/07/2012 Centralised Orphan - Designation EMA/OD/032/12 (2012)4775 of 04/07/2012
02/08/2013 Other procedure
05/08/2014 Centralised Orphan - Change of address